Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Flexion Therapeutics Inc
Flexion Therapeutics Inc logo

FLXN - Flexion Therapeutics Inc Share News

$11.41 0.4  3.5%

Last Trade - 01/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Sucker Stock
Market Cap £390.1m
Enterprise Value £415.7m
Revenue £59.5m
Position in Universe 3366th / 6711
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions FLXN Dividends
All News
All News Reuters News Company Announcements
BUZZ-Flexion: Up on FDA clearance of treatment for post-operative pain
Mon 1:43pm News
BRIEF-Flexion Announces FDA Clearance Of Investigational NDA For FX301
Mon 12:56pm News
Flexion Therapeutics Announces FDA Clearance of Investigational New Drug Application for FX301, a Novel Formulation of a Locally Administered NaV1.7 Inhibitor for Post-Operative Pain
Mon 12:30pm News
Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference
22nd Feb News
BRIEF-Flexion Therapeutics To Advance Investigational Gene Therapy Fx201 Into High Dose Cohort Of Phase 1 Clinical Trial In Knee Osteoarthritis And Expand Low And Mid Dose Treatment Groups
18th Feb News
Flexion Therapeutics to Advance Investigational Gene Therapy FX201 into High Dose Cohort of Phase 1 Clinical Trial in Knee Osteoarthritis and Expand Low and Mid Dose Treatment Groups
18th Feb News
National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®
1st Feb News
BRIEF-Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter And Full-Year 2020 Results
13th Jan News
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 Results
13th Jan News
Flexion Therapeutics to Present at the ICR | Westwicke Investment Conference
7th Jan News
Flexion Therapeutics to Present at the Needham Virtual Epilepsy and Pain Specialty CNS Therapeutics Conference
7th Dec '20 News
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4th Dec '20 News
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6th Nov '20 News
Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
5th Nov '20 News
BRIEF-Flexion Therapeutics Reports Third-Quarter 2020 Financial Results And Recent Business Highlights
4th Nov '20 News
BRIEF-Flexion Therapeutics Says Entered Into Equity Distribution Agreement Relating To Issuance And Sale From Time To Time By Co Of Up To $100 Million Shares
4th Nov '20 News
Flexion Therapeutics Reports Third-Quarter 2020 Financial Results and Recent Business Highlights
4th Nov '20 News
Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on November 4, 2020
29th Oct '20 News
BRIEF-Flexion Therapeutics Reports Q3 Sales Of $23.6 Mln
13th Oct '20 News
Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million
13th Oct '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.